Details for New Drug Application (NDA): 020137
✉ Email this page to a colleague
The generic ingredient in DEMADEX is torsemide. There are sixteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the torsemide profile page.
Summary for 020137
Tradename: | DEMADEX |
Applicant: | Roche |
Ingredient: | torsemide |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INTRAVENOUS | Strength | 20MG/2ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Aug 23, 1993 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INTRAVENOUS | Strength | 50MG/5ML (10MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Aug 23, 1993 | TE: | RLD: | Yes |
Expired US Patents for NDA 020137
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Roche | DEMADEX | torsemide | SOLUTION;INTRAVENOUS | 020137-002 | Aug 23, 1993 | ⤷ Sign Up | ⤷ Sign Up |
Roche | DEMADEX | torsemide | SOLUTION;INTRAVENOUS | 020137-002 | Aug 23, 1993 | ⤷ Sign Up | ⤷ Sign Up |
Roche | DEMADEX | torsemide | SOLUTION;INTRAVENOUS | 020137-002 | Aug 23, 1993 | ⤷ Sign Up | ⤷ Sign Up |
Roche | DEMADEX | torsemide | SOLUTION;INTRAVENOUS | 020137-002 | Aug 23, 1993 | ⤷ Sign Up | ⤷ Sign Up |
Roche | DEMADEX | torsemide | SOLUTION;INTRAVENOUS | 020137-002 | Aug 23, 1993 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription